import streamlit as st
import plotly.graph_objects as go
import google.generativeai as genai
import pandas as pd

# --- é é¢é…ç½®èˆ‡è‡ªå®šç¾© CSS ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

# ä¿®æ­£ï¼šå°‡ unsafe_allow_stdio æ”¹å› unsafe_allow_html
st.markdown("""
    <style>
    .main-title { font-size: 42px !important; font-weight: 700; color: #008080; padding-bottom: 20px; }
    html, body, [class*="css"] { font-size: 19px !important; line-height: 1.6; }
    .stAlert { border-radius: 12px; border: 1px solid #d1d9e6; }
    [data-testid="stSidebar"] { background-color: #f8f9fa; border-right: 1px solid #eee; }
    .reportview-container .main .block-container { padding-top: 2rem; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. è‡¨åºŠè©¦é©—è³‡æ–™åº« ---
TRIALS_DATA = [
    {
        "cancer_type": "Endometrial cancer (å­å®®å…§è†œç™Œ)",
        "name": "GU-US-682-6769 (SG vs Chemo)",
        "phase": "Phase 2/3",
        "stage": "Recurrence (å¾©ç™¼æ€§)",
        "treatment_line": "2nd or 3rd Line (äºŒ/ä¸‰ç·šæ²»ç™‚)",
        "drug_name": "Sacituzumab Govitecan (SG)",
        "rationale": "SG æ˜¯ä¸€ç¨®æ¨™é¶ Trop-2 çš„æŠ—é«”è—¥ç‰©è¤‡åˆé«” (ADC)ã€‚å…¶æ©Ÿè½‰ä¿‚åˆ©ç”¨ Anti-Trop-2 Antibody å°‡å¼·æ•ˆçš„ Topoisomerase I Inhibitor (SN-38) ç›´æ¥é€å…¥è…«ç˜¤ç´°èƒå…§ï¼Œé€é Bystander Effect (æ—è§€è€…æ•ˆæ‡‰) åŒæ™‚æ®ºå‚·å‘¨é‚Šä½è¡¨é” Trop-2 çš„ç™Œç´°èƒã€‚",
        "protocol": "SG 10mg/kg éœè„ˆæ³¨å°„ (D1, D8 Q21D) ç›´åˆ° PD æˆ–ä¸å¯è€å—ä¹‹æ¯’æ€§ï¼›å°ç…§çµ„ç‚ºé†«å¸«é¸æ“‡ä¹‹åŒ–ç™‚ (Doxo æˆ– Taxel)ã€‚",
        "inclusion": [
            "ç¶“çµ„ç¹”å­¸è­‰å¯¦ç‚ºé€²å±•æ€§æˆ–å¾©ç™¼æ€§ Endometrial Cancer",
            "å…ˆå‰å¿…é ˆè‡³å°‘æ¥å—éä¸€æ¬¡å« Platinum ä¹‹å…¨èº«æ€§åŒ–ç™‚",
            "å…ˆå‰å¿…é ˆæ¥å—é Anti-PD-1/L1 å…ç–«ç™‚æ³• (å¦‚ Pembro)",
            "ECOG Performance Status 0-1",
            "å…·å‚™å¯æ¸¬é‡ä¹‹ç—…ç¶ (RECIST 1.1)"
        ],
        "exclusion": [
            "Uterine Sarcoma (å­å®®è‚‰ç˜¤)",
            "å…ˆå‰æ¥å—éä»»ä½•é‡å° Trop-2 ä¹‹ ADC æ²»ç™‚",
            "å…·æœ‰æ´»å‹•æ€§ CNS Metastasis (ä¸­æ¨ç¥ç¶“è½‰ç§»)",
            "æ²»ç™‚å‰ 2 é€±å…§æ¥å—éå…¨èº«æ€§é¡å›ºé†‡æ²»ç™‚"
        ]
    },
    {
        "cancer_type": "Endometrial cancer (å­å®®å…§è†œç™Œ)",
        "name": "MK2870-033 (TroFuse-033)",
        "phase": "Phase 3",
        "stage": "Stage III/IV or Recurrence",
        "treatment_line": "1st Line / Maintenance (ä¸€ç·šç¶­æŒ)",
        "drug_name": "Sacituzumab Tirumotecan (Sac-TMT) + Pembro",
        "rationale": "æ­¤ç‚º Combo Therapyï¼Œçµåˆæ–°å‹ Trop-2 ADC (Sac-TMT) èˆ‡ PD-1 æŠ‘åˆ¶åŠ‘ (Pembro)ã€‚ADC èª˜å°è…«ç˜¤ç´°èƒæ­»äº¡é‡‹æ”¾æŠ—åŸï¼Œå¯è½‰åŒ–è…«ç˜¤å¾®ç’°å¢ƒï¼Œé€²è€Œæå‡å…ç–«ç™‚æ³•ä¹‹ç™‚æ•ˆã€‚",
        "protocol": "å¼•å°æœŸ (Induction): Carbo + Taxel + Pembro (Q3W x 6 cycles)ã€‚ç¶­æŒæœŸ (Maintenance): Pembro 400mg Q6W æ­é…æˆ–ä¸æ­é… Sac-TMTã€‚",
        "inclusion": [
            "Mismatch Repair Proficient (pMMR) ä¹‹æ‚£è€…",
            "æ–°è¨ºæ–·ä¹‹ Stage III/IV æˆ–åˆæ¬¡å¾©ç™¼ä¸”æœªæ¥å—éå…¨èº«æ²»ç™‚è€…",
            "å¿…é ˆæä¾›è…«ç˜¤æª¢é«”é€è‡³ä¸­å¤®å¯¦é©—å®¤ (UK) é€²è¡Œæª¢æ¸¬",
            "é©ç•¶ä¹‹è‚è…åŠŸèƒ½ (ANC â‰¥ 1,500/mmÂ³, Platelets â‰¥ 100,000/mmÂ³)"
        ],
        "exclusion": [
            "æ‰€æœ‰é¡å‹çš„ Uterine Sarcoma",
            "å…ˆå‰æ›¾ä½¿ç”¨é Pembro æˆ–å…¶ä»– PD-1/PD-L1 æŠ‘åˆ¶åŠ‘",
            "å…·æœ‰æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…"
        ]
    },
    {
        "cancer_type": "Ovarian cancer (åµå·¢ç™Œ)",
        "name": "DOVE (APGOT-OV07)",
        "phase": "Phase 2",
        "stage": "Recurrence (å¾©ç™¼æ€§)",
        "treatment_line": "Later Line (<5th)",
        "drug_name": "Dostarlimab + Bevacizumab",
        "rationale": "é‡å° Ovarian Clear Cell Carcinoma (OCCC)ã€‚åˆ©ç”¨ Dostarlimab é˜»æ–· PD-1 è·¯å¾‘æ¢å¾© T ç´°èƒæ®ºå‚·åŠ›ï¼Œè¼”ä»¥ Bevacizumab æŠ‘åˆ¶ VEGF åˆ†å­ï¼Œæ”¹å–„è…«ç˜¤è¡€ç®¡åŒ–ä¸¦å”åŒå¢å¼·å…ç–«åæ‡‰ã€‚",
        "protocol": "Arm A: Dostarlimab å–®ç¨ä½¿ç”¨ï¼›Arm B: Dostarlimab + Beva (15mg/kg Q3W)ï¼›Arm C: é†«å¸«é¸æ“‡ä¹‹éé‰‘é¡åŒ–ç™‚ (Gem/Doxo/Taxel)ã€‚",
        "inclusion": [
            "ç¶“çµ„ç¹”å­¸ç¢ºèªç‚º Ovarian Clear Cell Carcinoma (>50%)",
            "Platinum-resistant (æœ€è¿‘ä¸€æ¬¡å«é‰‘æ²»ç™‚ 12 å€‹æœˆå…§å¾©ç™¼è€…)",
            "å…ˆå‰æ²»ç™‚ç·šæ•¸ä¸è¶…é 5 ç·š",
            "å¹´æ»¿ 20 æ­²ä¸”å…·å‚™è¶³å¤ å™¨å®˜åŠŸèƒ½"
        ],
        "exclusion": [
            "å…ˆå‰æ›¾ä½¿ç”¨é Anti-PD-1/L1/L2 æˆ– CTLA-4 æ²»ç™‚",
            "éé€æ˜ç´°èƒç™Œä¹‹çµ„ç¹”å‹æ…‹ (å¦‚ High-grade Serous)",
            "è‡¨åºŠé¡¯è‘—ä¹‹è…¹æ°´æˆ–è…¸é˜»å¡ç—‡ç‹€"
        ]
    },
    {
        "cancer_type": "Ovarian cancer (åµå·¢ç™Œ)",
        "name": "DS8201-772 (T-DXd)",
        "phase": "Phase 2/3",
        "stage": "1st Line Maintenance (ä¸€ç·šç¶­æŒ)",
        "treatment_line": "Post-Platinum Maintenance",
        "drug_name": "Trastuzumab Deruxtecan (Enhertu)",
        "rationale": "æ¨™é¶ HER2 ä¹‹ ADCã€‚æ­è¼‰å¼·æ•ˆ Topoisomerase I Inhibitorï¼Œå° HER2 ä½è¡¨é”è…«ç˜¤å…·æœ‰æ¥µä½³æ®ºå‚·åŠ›ã€‚æ­¤è©¦é©—æ¢è¨åœ¨ç¬¬ä¸€ç·šåŒ–ç™‚ç©©å®šå¾Œï¼Œä½œç‚ºç¶­æŒæ²»ç™‚æ›¿ä»£ PARPi çš„æ½›åŠ›ã€‚",
        "protocol": "T-DXd 5.4mg/kg æ¯ 3 é€±çµ¦è—¥ä¸€æ¬¡ (Q3W)ï¼Œå¯æ­é…æˆ–ä¸æ­é… Bevacizumab 15mg/kgã€‚",
        "inclusion": [
            "HER2 è¡¨ç¾ (IHC 3+, 2+, æˆ– 1+) ç¶“ä¸­å¤®å¯¦é©—å®¤ç¢ºèª",
            "BRCA Wild-type æˆ– HRD çµæœé¡¯ç¤ºå° PARP Inhibitor ç™‚æ•ˆé æœŸä¸ä½³è€…",
            "ç¬¬ä¸€ç·š Platinum + Bevacizumab æ²»ç™‚ 6-8 é€±æœŸå¾Œé” Non-PD (CR/PR/SD)"
        ],
        "exclusion": [
            "æ‚£æœ‰æˆ–æ›¾æ‚£æœ‰éœ€é¡å›ºé†‡æ²»ç™‚ä¹‹ Interstitial Lung Disease (ILD) æˆ–è‚ºç‚",
            "å…ˆå‰æ¥å—éä»»ä½•é‡å° HER2 ä¹‹æ²»ç™‚ (å¦‚ Trastuzumab)",
            "LVEF (å·¦å¿ƒå®¤å°„å‡ºç‡) < 50%"
        ]
    }
]

# --- 2. å´é‚Šæ¬„ ---
with st.sidebar:
    st.markdown("### ğŸ¤– Gemini AI æ±ºç­–è¼”åŠ©")
    api_key = st.text_input("Gemini API Key", type="password")
    patient_notes = st.text_area("è¼¸å…¥æ‚£è€…è‡¨åºŠæ‘˜è¦", height=300, placeholder="ä¾‹å¦‚ï¼š65y/o OCCC, stage IIIC, s/p IP chemo...")
    
    if st.button("ğŸš€ é–‹å§‹åª’åˆè©¦é©—"):
        if api_key and patient_notes:
            try:
                genai.configure(api_key=api_key)
                model = genai.GenerativeModel('gemini-1.5-pro')
                prompt = f"ä½ æ˜¯ä¸€ä½å°ç£å©¦ç™Œå°ˆå®¶ã€‚è«‹æ ¹æ“šè©¦é©—è³‡æ–™ï¼š{TRIALS_DATA}ï¼Œåˆ†ææ‚£è€…ï¼š{patient_notes}ã€‚è«‹å»ºè­°é©åˆè©¦é©—ï¼Œèªªæ˜ç†ç”±ã€‚"
                response = model.generate_content(prompt)
                st.markdown("---")
                st.write(response.text)
            except Exception as e:
                st.error(f"AI é€£ç·šå¤±æ•—ï¼š{e}")

# --- 3. ä¸»é é¢ ---
st.markdown("<div class='main-title'>ğŸ—ï¸ å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªåœ°åœ–</div>", unsafe_allow_html=True)

def create_sankey(cancer_type):
    nodes = ["åˆè¨º (Dx)", "ä¸€ç·š (1st Line)", "ç¶­æŒ (Maint.)", "å¾©ç™¼ (Recurr.)", "è©¦é©— (Trial)"]
    sources, targets, values, labels = [], [], [], []
    for t in TRIALS_DATA:
        if t["cancer_type"].startswith(cancer_type):
            if "1st Line" in t["treatment_line"] and "Maintenance" not in t["treatment_line"]:
                sources.extend([0, 1]); targets.extend([1, 4]); values.extend([1, 1]); labels.extend(["æ¨™æº–æ²»ç™‚", t["name"]])
            elif "Maintenance" in t["treatment_line"]:
                sources.extend([1, 2]); targets.extend([2, 4]); values.extend([1, 1]); labels.extend(["åŒ–ç™‚ç©©å®š", t["name"]])
            elif "Recurrence" in t["stage"]:
                sources.extend([0, 3]); targets.extend([3, 4]); values.extend([1, 1]); labels.extend(["å¾©ç™¼", t["name"]])
    fig = go.Figure(data=[go.Sankey(
        node = dict(pad = 30, thickness = 25, label = nodes, color = "#008080"),
        link = dict(source = sources, target = targets, value = values, label = labels, color = "rgba(0, 128, 128, 0.1)")
    )])
    fig.update_layout(height=400, margin=dict(l=10, r=10, t=20, b=20))
    return fig

t_ec, t_oc = st.tabs(["å­å®®å…§è†œç™Œ (Endometrial)", "åµå·¢ç™Œ (Ovarian)"])
with t_ec: st.plotly_chart(create_sankey("Endometrial"), use_container_width=True)
with t_oc: st.plotly_chart(create_sankey("Ovarian"), use_container_width=True)

# --- 4. è©³æƒ…å¡ç‰‡ ---
st.divider()
selected_name = st.selectbox("è«‹é¸æ“‡è©¦é©—åç¨±ï¼š", [t["name"] for t in TRIALS_DATA])
t = next(item for item in TRIALS_DATA if item["name"] == selected_name)

st.markdown(f"### ğŸ§ª è—¥ç‰©æ©Ÿè½‰ï¼š{t['drug_name']}")
st.info(t['rationale'])

col1, col2 = st.columns(2)
with col1:
    st.markdown("#### ğŸ’‰ çµ¦è—¥ Protocol")
    st.success(t['protocol'])
with col2:
    st.markdown("#### âœ… å…¥æ¡ˆæ¢ä»¶ (Inclusion)")
    for inc in t['inclusion']: st.write(f"ğŸ”¹ {inc}")
    st.markdown("#### âŒ æ’é™¤æ¢ä»¶ (Exclusion)")
    for exc in t['exclusion']: st.write(f"ğŸ”¸ {exc}")
